Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | NR4A2 | P43354 | 9/20 | 0.56 |
| ▸ | PTPRC | P08575 | 1/20 | 0.55 |
| ▸ | PTPRF | P10586 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.52 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.52 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.49 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.49 |
| ▸ | RXRA | P19793 | 3/20 | 0.47 |
| ▸ | RXRB | P28702 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28767935 | 0.96 | MEN1 (0.70) | MEN1KMT2ANR4A2PTPRCPTPRF | |
| SCHEMBL31141980 | 0.90 | MEN1 (0.79) | MEN1KMT2ANR4A2PTPRCPTPN1 | |
| SCHEMBL18687040 | 0.86 | MEN1 (0.74) | MEN1KMT2ANR4A2NR4A1NR4A3 | |
| SCHEMBL862870 | 0.86 | MEN1 (0.93) | MEN1KMT2ANR4A2NR4A1NR4A3 | |
| SCHEMBL17089024 | 0.85 | MEN1 (0.61) | MEN1KMT2ANR4A2NR4A1NR4A3 | |
| SCHEMBL7943171 | 0.85 | MEN1 (0.72) | MEN1KMT2ANR4A2PTPRCPTPN1 | |
| SCHEMBL17089120 | 0.83 | MEN1 (0.59) | MEN1KMT2ANR4A2PTPRCPTPN1 | |
| SCHEMBL1426961 | 0.82 | MEN1 (1.00) | MEN1KMT2ANR4A2NR4A1NR4A3 | |
| SCHEMBL6841528 | 0.82 | MEN1 (0.69) | MEN1KMT2ANR4A2NR4A1NR4A3 | |
| SCHEMBL2650306 | 0.82 | MEN1 (0.69) | MEN1KMT2ANR4A2PTPRCPTPRF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117816250-B | Rhenium-based supported catalyst, preparation thereof and application thereof in synthesis of rose ether intermediate | 山东新和成药业有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117816250-A | Rhenium-based supported catalyst, preparation thereof and application thereof in synthesis of rose ether intermediate | 山东新和成药业有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-8034952-B2 | Supramolecular assemblies and building blocks | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-10-11 | — | — | US | disclosed |
| US-8034952-B2 | Supramolecular assemblies and building blocks | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-10-11 | — | — | US | disclosed |
| US-20090143596-A1 | Supramolecular Assemblies and Building Blocks | UNIVERSITY OF SOUTH FLORIDA (US) | 2009-06-04 | — | — | US | disclosed |
| US-20090143596-A1 | Supramolecular Assemblies and Building Blocks | UNIVERSITY OF SOUTH FLORIDA (US) | 2009-06-04 | — | — | US | disclosed |
| EP-0785920-B1 | MULTIFUNCTIONAL CROSS-LINKING REAGENTS FOR HEMOGLOBIN, AND CROSS-LINKED HEMOGLOBIN CONJUGATES | KLUGER RONALD (CA) | 2000-05-17 | — | — | EP | disclosed |
| EP-0785920-A1 | MULTIFUNCTIONAL CROSS-LINKING REAGENTS FOR HEMOGLOBIN, AND CROSS-LINKED HEMOGLOBIN CONJUGATES | KLUGER, Ronald (CA) | 1997-07-30 | — | — | EP | disclosed |
| WO-1997000236-A1 | MULTIFUNCTIONAL CROSS-LINKING REAGENTS FOR HEMOGLOBIN, AND CROSS-LINKED HEMOGLOBIN CONJUGATES | KLUGER RONALD (CA) | 1997-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143596-A1 | Supramolecular Assemblies and Building Blocks | TERB1, TBCB, PARG | MEN1 712/4885KMT2A 3210/4885NR4A2 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.